Huadong Medicine Co., Ltd

Huadong Medicine Co., Ltd. is a comprehensive pharmaceutical enterprise founded in 1993 and headquartered in Hangzhou, Zhejiang Province. The company was listed on the Shenzhen Stock Exchange in December 1999. With over 30 years of development, Huadong Medicine operates across the entire pharmaceutical industry chain, specializing in pharmaceutical research and development, production, and marketing. The company has established a strong presence in various segments, including pharmaceutical business, aesthetic medicine, and industrial microbiology. The company’s pharmaceutical operations focus on specialized and chronic diseases, with core product lines in areas such as chronic nephrosis, transplantation immunity, and digestive health. Huadong Medicine has built a robust network in Zhejiang Province, ranking among the top pharmaceutical enterprises in China. Its aesthetic medicine segment has launched over 20 products and is committed to providing integrated solutions through innovative therapies. Additionally, the company is expanding its industrial microbiology sector, leveraging its R&D capabilities to enhance its market position and product offerings.

1.Open innovative medicine R&D system and continuously improved innovation ability 2.Comprehensive ability in developing international businesses 3.Diverse product lines for specialized and chronic diseases, and comprehensive competitiveness in diabetes treatment and care 4.Leading professional pharmaceutical care team and extensive market network in China 5.High-end international aesthetic medicine product lines that cover noninvasive and micro-invasive mainstream non-operative fields 6.Constant efforts in developing industrial microbiology sector based on solid R&D and industrial base 7. Prudent and pragmatic operation style, and stable returns to shareholders